Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Swiss Investment Managers debuts Europe's first director's dealings fund

Monday, September 05, 2011

Athanasios T. Ladopoulos
Opalesque Industry Update - 'Swiss Investment Managers' (SIM) will launch the "Directors Dealings Fund" (DDF) in September, the first hedge fund in Europe and US investing solely in the reported share dealings of company directors and senior corporate executives in their own firms.

Investing in listed companies, DDF will base its long or short investment decisions on publicly announced reports of transactions by company directors and senior management who are using their own money to buy or sell equity in their own firms.

SIM's fund managers will employ a counterintuitive approach, using a contrarian interpretation of directors' and managers' share dealings. The strategy has a low 0.2% to 0.4% correlation to equity capital markets and targets low volatility with strong risk-adjusted returns, generating real alpha. The fund is aiming for a risk-adjusted return of around 15%.

DDF is managed by Athanasios T. Ladopoulos, a partner in Swiss Investment Managers, supported by George Muzea, who is considered the "father" of the so-called Director Dealing and Corporate Insiders Transactions strategy, acting as senior advisor. It is a "specialised investment fund" (SIF / FIS), registered in Luxembourg with the CSSF.

The fund will not use leverage or derivatives and thus will have no associated collateral risk. It will invest in large- and mid-cap European and US companies enabling liquidity terms which are expected to make it highly appealing to a broad range of eligible high net worth individuals (HNWI's), family office and institutional investors.

"Directors and executive management team members generally know more about the companies they manage than outsiders, such as broker analysts or fund managers," points out Ladopoulos. "When directors and executives buy significant amounts of shares, that's a strong signal something good will happen. Conversely, when they sell significant amounts of shares, it's a signal of tough times ahead. DDF combines intellectual capital with proprietary investment management mechanisms to analyse such activities and thus is well placed to take advantage of these dealings."

(press release

km

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its